Abstract
According to our results the long-term daily oral supplementation of 6 mg vitamin B6 was sufficient for prevention of vitamin B6 deficiency in chronic renal failure, regular dialysis treatment and CAPD groups of patients. Haemodialysis and charcoal haemoperfusion have led to non-significant decrease of erythrocyte vitamin B6. A favourable effect was found of daily oral administration of 50 mg pyridoxine on electrophoretic mobility of peripheral blood lymphocytes and cellular immunity.
Similar content being viewed by others
References
Bayoumi, R. A., Rosalki, S. B.: Evaluation of methods of coenzyme activation of erythrocyte enzymes for detection of deficiency of vitamins B1, B2 and B6.Clin. Chem., 22, 327 (1976).
Blumberg, A., Hanck, A., Sander, G.: Vitamin nutrition in patients on continuous ambulatory peritoneal dialysis (CAPD).Clin. Nephrol., 20, 244 (1983).
Boeschoten, E. W., Schrijver, J., Krediet, R. U. N., Schreurs, W. H. P., Arisz, L.: Deficiencies of vitamins in CAPD patients: The effect of supplementation.Nephrol. Dial. Transplant. 2, 187 (1988).
Casciato, D. A., McAdam, L. P., Kopple, J. D., Bluestone, R., Goldberg, L. S., Clements, P. J., Knutson, D. W.: Immunologic abnormalities in hemodialysis patients: Improvement after pyridoxine therapy.Nephron, 38 9 (1984).
Chandra, R. K., Sudhakaran, L.: Regulation of immune responses by vitamin B6.Ann. N. Y. Acad. Sci., 585, 1404 (1990).
DeBari, V. A., Frank, O., Baker, H., Needle, M. A.: Water soluble vitamins in granulocytes, erythrocytes, and plasma obtained from chronic hemodialysis patients.Am. J. Clin. Nutr., 39, 410 (1984).
Dobbelstein, H., Körner, W. F., Mempel, W., Grosse-Wilde, H., Edel, H. H.: Vitamin B6 deficiency in uremia and its implications for the depression of immune responses.Kidney Int., 5, 233 (1974).
Gäng, V., Schulz, R. J., Kult, J., Heidland, A.: Vitamin B6-Mangel und-Substitution bei chronischer Urämie.Klin. Wochenschr., 53, 335 (1975).
Hayashi, H., Toyama, N., Oguchi, Y., Matsunaga, K., Fujji, M., Hirose, H., Yoshikumi, C., Hotta, T., Yanagisawa, M.: Measurement of mixed cell populations by an automated cell electrophoretic instrument. In: H. Hirai (ed.): Electrophoresis '83. Walter de Gruyter, Berlin-New York 1984, pp. 373–377.
Heaf, J. G.: Liver function tests and pyridoxine levels in uremia.Nephron, 30, 131 (1982).
Henderson, I. S., Leung, A. C. T., Shenkin, A.: Vitamin status in continuous ambulatory peritoneal dialysis.Perit. Dial. Bull., 4, 143 (1984).
Kaplan, M. E., Clark, C.: An improved rosetting assay for detection of human T-lymphocytes.J. Immunol. Meth., 5, 131 (1974).
Kleiner, M. J., Tate, S. S., Sullivan, J. F., Chami, J.: Vitamin B6 deficiency in maintenance dialysis patients: Metabolic effects of repletion.Am. J. Clin. Nutr., 33, 1612 (1980).
Kopple, J. D., Swendseid, M. E.: Vitamin nutrition in patients undergoing maintenance hemodialysis.Kidney Int., 7 (Suppl. 2), 79 (1975).
Kopple, J. D., Mercurio, K., Blumenkrantz, M. J., Jones, M. R., Tallos, J., Roberts, C., Card, B., Saltzman, R., Casciato, D. A., Swendseid, M. E.: Daily requirement for pyridoxine supplements in chronic renal failure.Kidney Int., 19, 694 (1981).
Kopple, J. D., Blumenkrantz, M. J.: Nutritional requirements for patients undergoing continuous ambulatory peritoneal dialysis.Kidney Int., 24 (Suppl. 16), 295 (1983).
Lacour, B., Parry, C., Drüeke, T., Touam, M., Kreis, H., Bailly, M., Durand, D.: Pyridoxal 5′-phosphate deficiency in uremic undialysed, hemodialysed and non-uremic kidney transplant patients.Clin. Chim. Acta, 127, 205 (1983).
Laso Guzmán, F. J., Gonzáles-Buitrago, J. M., Vela, R., Cava, F., de Castro, S.: Vitamin B6 status in uremia.Klin. Wochenschr., 68, 183 (1990).
Mydlík, M., Derzsiová, K., Válek, A., Szabó, T., Dandár, V., Takáč, M.: Vitamins and continuous ambulatory peritoneal dialysis (CAPD).Int. Urol. Nephrol., 17, 281 (1985).
Ramirez, G., Chen, M., Boyce, H. W. Jr., Fuller, S. M., Butcher, D. E., Brueggemeyer, C. D., Newton, J. L.: The plasma and red cell vitamin B levels of chronic hemodialysis patients: A longitudinal study.Nephron, 42, 41 (1986).
Ross, E. A., Shah, G. M., Reynolds, R. D., Sabo, A., Pichon, M.: Vitamin B6 requirements of patients on chronic peritoneal dialysis.Kidney Int., 36, 702 (1989).
Sjögren, U., Thysell, H., Lindholm, T.: The influence of vitamin B6 supplementation of the bone marrow morphology in patients on regular haemodialysis treatment. A double-blind study.Scand. J. Urol. Nephrol., 13, 101 (1979).
Spanuth, C. L. Jr., Warnock, L. G., Wagner, C., Stone, W. J.: Increased plasma clearance of pyridoxal 5′-phosphate in vitamin B6-deficient uremic man.J. Lab. Clin. Med., 90, 632 (1977).
Teehan, B. P., Smith, L. J., Sigler, M. H., Gilgore, G. S., Schleiser, C. R.: Plasma pyridoxal-5′-phosphate levels and clinical correlations in chronic hemodialysis patients.Am. J. Clin. Nutr., 31, 1932 (1978).
Wolfson, M., Kopple, J. D.: The effects of vitamin B-6 deficiency in chronically azotemic and sham-operated rats.Kidney Int. 32 (Suppl. 22), 162 (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mydlík, M., Derzsiová, K., Guman, M. et al. Vitamin B6 requirements in chronic renal failure. International Urology and Nephrology 24, 453–457 (1992). https://doi.org/10.1007/BF02550641
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02550641